Emergent Biosolutions
EBS
EBS
161 hedge funds and large institutions have $241M invested in Emergent Biosolutions in 2025 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 53 increasing their positions, 40 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
5% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 40
1% more funds holding
Funds holding: 160 → 161 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
161
Holding in Top 10
1
Calls
$2.69M
Puts
$1.17M
Top Buyers
| 1 | +$16.1M | |
| 2 | +$7.57M | |
| 3 | +$4.25M | |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$3.55M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$3.33M |
Top Sellers
| 1 | -$11.1M | |
| 2 | -$4.72M | |
| 3 | -$3.86M | |
| 4 |
Goldman Sachs
New York
|
-$3.26M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.5M |
